Results of RCTs comparing aminophylline to β2 adrenergic agonist.

Figshare2016-08-03 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Results_of_RCTs_comparing_aminophylline_to_sub_2_sub_adrenergic_agonist_/3510544 数据链接链接失效反馈

官方服务：

资源简介：

Results of RCTs comparing aminophylline to β2 adrenergic agonist.

创建时间：

2016-08-03

GRADE profile evidence of the included studies for pemetrexed VS BSC/placebo.

药物疗效比较

临床评估

GRADE profile evidence of the included studies for pemetrexed VS BSC/placebo.

Figshare2016-03-11 更新20

Data Sheet 1_Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review.docx

免疫治疗相关心肌炎

药物疗效比较

BackgroundImmune checkpoint inhibitor-associated myocarditis (ICI-M) is a rare yet potentially fatal complication of immunotherapy, with no standardized treatment protocol due to limited data. The use

NIAID Data Ecosystem00

DataSheet_4_Comparing the efficacy of glucocorticoids and anti-VEGF in treating diabetic macular edema: systematic review and comprehensive analysis.docx

糖尿病性黄斑水肿治疗

药物疗效比较

IntroductionThe aim of this study was to better understand the efficacy of various drugs, such as glucocorticoids and anti-vascular endothelial growth factors (VEGF), in the treatment of diabetic macu

NIAID Data Ecosystem00

Supporting data for "Engineering of Inhalable Nanoagglomerate Dry Powders for Treatment of Respiratory Diseases: Rational Development, Characterization, and Evaluation"

药物递送系统

呼吸系统疾病治疗

This dataset includes supporting data for "Engineering of Inhalable Nanoagglomerate Dry Powders for Treatment of Respiratory Diseases: Rational Development, Characterization, and Evaluation". The stud

Figshare2025-07-16 更新10

Data Sheet 1_Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma.docx

肝细胞癌治疗

药物疗效比较

BackgroundProgrammed cell death-1/programmed cell death-ligand 1 (PD-[L]1) inhibitors plus bevacizumab (or biosimilars) or tyrosine kinase inhibitors (TKIs) have been widely used for the first-line tr

NIAID Data Ecosystem00

Results of RCTs comparing aminophylline to β2 adrenergic agonist.

资源简介：

相关数据集